Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
Spectral AI (Nasdaq: MDAI), an AI company specializing in medical diagnostics for wound care, has announced its schedule for reporting 2024 second quarter financial results. The company will release its financial report on Monday, August 12, 2024, after the stock market closes. Following the release, Spectral AI will host a conference call at 5:00 pm Eastern Time to discuss the results.
Investors interested in participating in the live call can dial 833-630-1956 for U.S. callers or 412-317-1837 for international callers. Additionally, a simultaneous webcast of the call will be accessible from the Events & Presentations section of the company's Investor Relations page at https://investors.spectral-ai.com/news-events/events.
Spectral AI (Nasdaq: MDAI), un'azienda di intelligenza artificiale specializzata nella diagnostica medica per la cura delle ferite, ha annunciato il suo programma per la pubblicazione dei risultati finanziari del secondo trimestre del 2024. L'azienda rilascerà il suo rapporto finanziario lunedì 12 agosto 2024, dopo la chiusura del mercato azionario. Dopo il rilascio, Spectral AI ospiterà una chiamata in conferenza alle 17:00 ora orientale per discutere i risultati.
Gli investitori interessati a partecipare alla chiamata dal vivo possono comporre il numero 833-630-1956 per i chiamanti statunitensi o 412-317-1837 per i chiamanti internazionali. Inoltre, una trasmissione simultanea della chiamata sarà accessibile dalla sezione Eventi e Presentazioni della pagina delle Relazioni con gli Investitori dell'azienda all'indirizzo https://investors.spectral-ai.com/news-events/events.
Spectral AI (Nasdaq: MDAI), una empresa de inteligencia artificial especializada en diagnósticos médicos para el cuidado de heridas, ha anunciado su programación para informar sobre los resultados financieros del segundo trimestre de 2024. La compañía publicará su informe financiero el lunes 12 de agosto de 2024, después del cierre del mercado de valores. Después de la publicación, Spectral AI llevará a cabo una conferencia telefónica a las 5:00 pm hora del Este para discutir los resultados.
Los inversores interesados en participar en la llamada en vivo pueden marcar 833-630-1956 para los llamantes de EE. UU. o 412-317-1837 para los llamantes internacionales. Además, una transmisión simultánea de la llamada estará disponible en la sección de Eventos y Presentaciones de la página de Relaciones con Inversores de la compañía en https://investors.spectral-ai.com/news-events/events.
스펙트럴 AI (Nasdaq: MDAI), 상처 치료를 위한 의료 진단에 특화된 AI 기업이 2024년 2분기 재무 결과 발표 일정을 발표했습니다. 회사는 2024년 8월 12일 월요일에 주식 시장 폐장 이후 재무 보고서를 발표할 예정입니다. 발표 후 스펙트럴 AI는 동부 표준시 오후 5시에 결과에 대해 논의하기 위한 컨퍼런스 콜를 개최합니다.
실시간 전화 회의에 참여하고자 하는 투자자는 미국 발신자는 833-630-1956, 국제 발신자는 412-317-1837으로 전화할 수 있습니다. 또한, 이 호출의 동시 웹캐스트는 회사의 투자자 관계 페이지의 이벤트 및 프레젠테이션 섹션에서 접근할 수 있습니다: https://investors.spectral-ai.com/news-events/events.
Spectral AI (Nasdaq: MDAI), une entreprise d'IA spécialisée dans le diagnostic médical pour les soins des blessures, a annoncé son calendrier pour la publication des résultats financiers du deuxième trimestre 2024. L'entreprise publiera son rapport financier le lundi 12 août 2024, après la fermeture du marché boursier. Après la publication, Spectral AI organisera une conférence téléphonique à 17h00, heure de l'Est, pour discuter des résultats.
Les investisseurs intéressés à participer à l'appel en direct peuvent composer le 833-630-1956 pour les appelants américains ou le 412-317-1837 pour les appelants internationaux. De plus, une webdiffusion simultanée de l'appel sera accessible depuis la section Événements et Présentations de la page Relations Investisseurs de l'entreprise à l'adresse https://investors.spectral-ai.com/news-events/events.
Spectral AI (Nasdaq: MDAI), ein KI-Unternehmen, das sich auf medizinische Diagnosen im Wundmanagement spezialisiert hat, hat seinen Zeitplan für die Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 bekannt gegeben. Das Unternehmen wird seinen Finanzbericht am Montag, den 12. August 2024, nach Börsenschluss veröffentlichen. Nach der Veröffentlichung wird Spectral AI um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren, die an der Live-Konferenz teilnehmen möchten, können die Nummer 833-630-1956 für Anrufer aus den USA oder 412-317-1837 für internationale Anrufer wählen. Darüber hinaus wird eine gleichzeitige Webcast der Konferenz im Abschnitt Veranstaltungen & Präsentationen der Investor-Relations-Seite des Unternehmens unter https://investors.spectral-ai.com/news-events/events verfügbar sein.
- None.
- None.
DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2024 on Monday, August 12, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.
Investors interested in participating in the live call can dial:
- 833-630-1956 - U.S.
- 412-317-1837 - International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is a predictive device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to change the current standard of care, the DeepView System is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Investors:
The Equity Group
Devin Sullivan
Managing Director
dsullivan@equityny.com
Conor Rodriguez
Analyst
crodriguez@equityny.com
FAQ
When will Spectral AI (MDAI) release its Q2 2024 financial results?
What time is Spectral AI's (MDAI) Q2 2024 earnings conference call?
How can investors participate in Spectral AI's (MDAI) Q2 2024 earnings call?
Where can I find the webcast for Spectral AI's (MDAI) Q2 2024 earnings call?
